The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

NCT03151005 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome (PCOS)
Overweight
Obesity

Interventions

DRUG: Metformin-GLP-1 Receptor Agonist
DRUG: Metformin-Oral Contraceptive(OC)

Sponsor

Xinqiao Hospital of Chongqing